These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 12882086)
1. DNA ploidy of bladder cancer using bladder biopsy supernate specimens. Loughman NT; Lin BP; Dent OF; Newland RC Anal Quant Cytol Histol; 2003 Jun; 25(3):146-58. PubMed ID: 12882086 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up. Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058 [TBL] [Abstract][Full Text] [Related]
3. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder. al-Abadi H; Nagel R J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829 [TBL] [Abstract][Full Text] [Related]
4. Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladder. Slaton JW; Dinney CP; Veltri RW; Miller CM; Liebert M; O'Dowd GJ; Grossman HB J Urol; 1997 Sep; 158(3 Pt 1):806-11. PubMed ID: 9258087 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors. Miao T; Wang Z; Sang N; Xiong R; Cao S Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623 [TBL] [Abstract][Full Text] [Related]
6. Differential diagnosis and evaluation of the clinical course of transurethrally resected T1G3 urothelial carcinoma of the bladder by DNA image cytometry. Biesterfeld S; Borchers H; Jellouschek H; Bono AV; Altwein JE; Algaba F; Jakse G Anticancer Res; 2005; 25(5):3243-9. PubMed ID: 16101134 [TBL] [Abstract][Full Text] [Related]
7. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder. Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707 [TBL] [Abstract][Full Text] [Related]
8. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder. Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471 [TBL] [Abstract][Full Text] [Related]
9. Intratumoral heterogeneity in DNA ploidy of bladder carcinomas. Sasaki K; Hamano K; Kinjo M; Hara S Oncology; 1992; 49(3):219-22. PubMed ID: 1495749 [TBL] [Abstract][Full Text] [Related]
10. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder. Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620 [TBL] [Abstract][Full Text] [Related]
11. Identification of a high risk subgroup of grade 1 transitional cell carcinoma using image analysis based deoxyribonucleic acid ploidy analysis of tumor tissue. Hemstreet GP; Rollins S; Jones P; Rao JY; Hurst RE; Bonner RB; Hewett T; Smith BG J Urol; 1991 Dec; 146(6):1525-9. PubMed ID: 1942333 [TBL] [Abstract][Full Text] [Related]
12. [Studies on nuclear DNA content in bladder cancers using flow cytometry]. Toyota K Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374 [TBL] [Abstract][Full Text] [Related]
13. Image cytometric DNA analysis in transitional cell carcinoma of the bladder. Schapers RF; Ploem-Zaaijer JJ; Pauwels RP; Smeets AW; van den Brandt PA; Tanke HJ; Bosman FT Cancer; 1993 Jul; 72(1):182-9. PubMed ID: 8508404 [TBL] [Abstract][Full Text] [Related]
14. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors. Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839 [TBL] [Abstract][Full Text] [Related]
15. DNA ploidy and S phase fraction in human bladder cancer. Relation to survival and histological grade (WHO). Lipponen PK; Eskelinen MJ; Collan Y; Pesonen E; Ventilä T; Sotarauta M; Nordling S Urol Int; 1990; 45(1):4-9. PubMed ID: 2305493 [TBL] [Abstract][Full Text] [Related]
16. DNA ploidy by image cytometry in urothelial carcinomas. Comparison of touch imprints and paraffin-embedded biopsies from 31 patients. Mainguené C; Choquenet C; Deplano C; Gavelli A; Clément N; Vanzo E; Hofman P Anal Quant Cytol Histol; 1997 Oct; 19(5):437-42. PubMed ID: 9349904 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy. Nakopoulou L; Constantinides C; Papandropoulos J; Theodoropoulos G; Tzonou A; Giannopoulos A; Zervas A; Dimopoulos C Urology; 1995 Sep; 46(3):334-40. PubMed ID: 7660508 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of DNA image cytometry in Libyan breast cancer. Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y Oncology; 2012; 83(3):165-76. PubMed ID: 22906963 [TBL] [Abstract][Full Text] [Related]
19. Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer. Pycha A; Mian C; Haitel A; Hofbauer J; Wiener H; Marberger M J Urol; 1997 Jun; 157(6):2116-9. PubMed ID: 9146595 [TBL] [Abstract][Full Text] [Related]
20. [The clinical significance of flow cytometric DNA measurement of paraffin specimen in bladder tumor]. Wang Z Zhonghua Wai Ke Za Zhi; 1990 Aug; 28(8):505-8, 512. PubMed ID: 2086120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]